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Abstract—The estimation of myocardial blood flow (MBF) in
dynamic PET can be biased by many different processes. A major
source of error, particularly in clinical applications, is patient
motion. Patient motion, or gross motion, creates displacements
between different PET frames as well as between the PET frames
and the CT-derived attenuation map, leading to errors in MBF
calculation from voxel time series. Motion correction techniques
are challenging to evaluate quantitatively and the impact on MBF
reliability is not fully understood. Most metrics, such as Signal
to Noise Ratio (SNR), are characteristic of static images, and are
not specific to motion correction in dynamic data. This study
presents a new approach of estimating motion correction quality
in dynamic cardiac PET imaging. It relies on calculating a MBF
surrogate, K1, along with the uncertainty on the parameter. This
technique exploits a Bayesian framework, representing the kinetic
parameters as a probability distribution, from which uncertainty
measures can be extracted. If the uncertainty extracted is high
the parameter studied is considered to have high variability
- or low confidence - and vice versa. The robustness of the
framework is evaluated on simulated time activity curves to
ensure that uncertainties are consistently estimated at multiple
levels of noise. Our framework is applied on 40 patient datasets,
divided in 4 motion magnitude categories. Experienced observers
manually realigned clinical datasets with 3D translations to
correct for motion. K1 uncertainties were compared before
and after correction. A reduction of uncertainty after motion
correction of up to 60% demonstrates the benefit of motion
correction in dynamic PET and as well as provides evidence
of the usefulness of the new method presented.
Index Terms—Myocardial Blood flow - Variational Bayes -
dynamic PET imaging - motion correction - uncertainty mea-
surements.
I. INTRODUCTION
Myocardial Perfusion Imaging (MPI) with hybridPositron Emission Tomography (PET) / Computed
Tomography (CT) is an established technology for assessing
coronary artery disease (CAD) [1]. Recent studies have shown
that kinetic modelling with dynamic PET provides clinicians
with quantitative estimates of Myocardial Blood Flow (MBF),
which offers potentially superior diagnosis compared to stan-
dard MPI [2], [3], [4]. Quantification and standardization of
MBF is an important area of research for dynamic cardiac PET
imaging [5], [6], [7]. By comparing MBF values between a
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resting state and after a response to physiological or pharma-
cological stress, clinicians can also evaluate Myocardial Flow
Reserve (MFR), which is the ratio of stress MBF and rest
MBF. Together, MBF and MFR can improve diagnosis, for
example in patients with triple vessel coronary disease [8].
However, despite its advantages, the absolute quantification
of MBF is not used routinely in the clinic due to a lack
of clinical standardization [1], [9]. MBF estimates can be
affected by many factors, such as the choice of reconstruction
method [10], temporal sampling strategy [11], post-processing
methods [6] and patient motion [12].
The impact of reconstruction and acquisition parameters can
be minimized with standardization and quality control [1], but
patient motion cannot be avoided and is one of the most
common issues with dynamic PET in clinical applications,
despite careful patient preparation and coaching during the
scan. With motion, the region studied might not reflect the
same tissue over different image frames, and consequently
the final estimate of MBF is less reliable. Moreover, patient
motion, or gross motion, is non-periodic, unlike respiratory or
cardiac motion. Thus it can be difficult to predict its impact
on MBF estimates [13]. Clinical studies, with 90 [13], 225
[14] and 236 patients [15], showed that moderate or high
motion can appear relatively frequently, for 30% to 40% of
the scans, and is more common in stress scans than in rest
scans [14]. In addition to frequent occurrence, motion also
has a significant impact on MBF estimates. A recent study
[12] determined, through computer simulations, that severe
patient motion (up to 2cm) could lead to 500% error in MBF
measurement. The impact of motion on clinical data has also
been evaluated, demonstrating that motion can be a source
of error in MBF estimation [14], [15]. Additionally, motion
does not only induce errors within the dynamic PET image
but also between the PET series and the CT. A good PET/CT
alignment is important for attenuation correction purposes and
can be another source of error in the MBF estimation [16].
Motion correction is necessary to perform accurate MBF
estimation, but it remains challenging to evaluate quantitatively
its accuracy on clinical data, because the ground truth is
unavailable. Simulations - with defined ground truth - can be
performed in order to establish the performance of motion
correction [12], but cannot capture systematically what is
happening in actual clinical data. Some groups have evaluated
the impact of motion correction on clinical images with
generic image quality metrics, such as Signal to Noise Ratio
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(SNR) [17], [18]. Using this approach, an increase of the
SNR calculated on the summed image of the dynamic series
could demonstrate better image quality, this being associated
with success in motion correction [19]. Since this metric is
derived from a static image, it cannot characterize the effect
of motion correction on dynamic data specifically, which is
important for MBF quantification because it relies on features
within the dynamic series. Hence a common assessment of the
quality of motion correction remains a visual evaluation by a
clinical expert [12], [13], which is not objective, being subject
to experience and interpretation of the observer. Moreover,
these types of metrics do not relate directly with an objective
assessment on uncertainty of kinetic parameters and MBF
directly. It is recommended that motion correction should be
performed before or during reconstruction of the dynamic PET
data [6], [12], but currently there is no quantitative way to
determine whether motion correction provides more reliable
MBF estimates in an individual patient.
To estimate uncertainties of parameters in a model, two
different approaches can be used, namely the frequentist and
the Bayesian [20]. Despite being often interpreted the same
way, some conceptual differences hold. In the frequentist
strategy, simulations or clinical studies repeated under the
same conditions can be performed to estimate variability or
uncertainty in the estimated parameters. By compiling the
results of these experiments, statistics can be calculated, from
which confidence intervals can be drawn. Yet no inference is
possible on the probability that the result of a single exper-
iment lies within the confidence interval. This approach has
for example been used to measure the impact of the Renkin-
Crone parameters on the MBF variability [5]. Nevertheless
this technique cannot be used for assessing the variation of a
parameter in a single dataset, and hence the effect on parameter
variability of a motion correction technique on a particular
clinical dataset. The alternative is to appeal to Bayes’ theorem,
which offers a natural framework to estimate uncertainties of
parameters in a model [21]. In a Bayesian framework, each
parameter is represented as a probability distribution instead
of a single value, from which an uncertainty metric can be
drawn. There are various methods to solve the Bayes inference
problem [22]. Monte Carlo Markov Chain (MCMC), a family
of sampling algorithms, is commonly accepted as the gold
standard [23]. However, due to its expensive computations and
long processing time [24], it can be impractical to use it in a
clinic for kinetic modelling in medical images, especially for
voxel-wise analysis [25]. Another way to perform Bayesian
inference is to use Variational Bayes (VB) [26], [27], which
is a fully Bayesian approach that uses variational theory to
approximate the solution to the posterior distribution that
is the output of a Bayesian analysis. Thanks to its lower
computational cost VB has already been successfully applied
to kinetic modelling in medical imaging [28] and also PET
kinetic modelling for neurology applications [29].
This study proposes a novel method to assess the motion
correction of dynamic cardiac PET data, by evaluating the
uncertainty of the MBF estimate, which is derived from the
VB framework. Specifically, it is a quantitative way to look
at the impact of motion correction on the expected decrease
Fig. 1. Central vertical long axis view of the last 5 minutes summed over
a 6 minutes dynamic PET cardiac acquisition, started after tracer injection.
The green rectangle is the ROI that samples the blood input function in the
left ventricle, at the base of the left ventricular cavity. The shape with white
contours is the segmentation of the myocardial tissue. The transfer between
the blood and the myocardium is modelled by a kinetic model.
of uncertainty after correction. The method is also used to
investigate the difference of performing motion correction
before or after reconstruction of the PET data. This paper is
organized as follows. Section II reviews the theory of PET
kinetic modelling and VB inference. Section III provide details
on the simulation experiment made to validate the use of VB
for measuring MBF uncertainty, as well as the methods applied
to compare uncertainties before and after motion correction.
Section IV shows the results for the simulations and the
clinical datasets. Those results are ultimately discussed in
section V.
II. THEORY
A. MBF estimation and PET compartmental models
Computation of MBF requires kinetic modelling of Time
Activity Curves (TACs) of the myocardial tissue. TACs
represent the evolution of the tracer as a function of time, and
can be described by a kinetic model, from which parameters
are then subsequently used to compute the MBF.
To compute MBF, TACs are derived from two Regions of
Interest (ROIs): the left ventricular (LV) cavity to obtain the
arterial blood and the myocardial tissue, as shown in Fig. 1.
The choice of the response function, which describes the
residence of the tracer within the tissue, is usually directly
inspired by the physiological behavior of the tissue studied
[30]. In PET kinetic modeling, compartmental models have
been traditionally used for describing the uptake of the tracer
in the tissue [31]. Each compartment of the model represents
a possible state of the tracer, specifically its physical location
or its chemical form. The model depends mainly on the
tracer used and the type of the tissue studied. For the tracer
Rubidium-82 (Rb-82), used for MBF quantification in this
work, the model used is a one-tissue compartment model
[30], [32]. The response function Ctiss(t) modeling the tracer
exchange from the blood to the tissue is as follows:
Ctiss(t) = K1 exp(−k2t) ~ Ca(t) (1)
where Ca(t) is the time course of the concentration of the
tracer in arterial blood also called blood input function; K1
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and k2 are the two exchange rates between the blood and the
tissue; and ~ is the convolution operator.
In addition, a partial volume effect correction from the
arterial blood is applied [30], as shown in Fig. 2:
Cm(t) = (1− Vb)Ctiss(t) + VbCa(t) (2)
where Vb is the fraction of volume occupied by arterial blood
within the tissue, defined between 0 and 1; Cm(t) is the
concentration measured through the dynamic PET series.
Since the blood fraction ratio Vb is by definition constrained









where x is a hyper-parameter, which can take values on R.
In order to obtain the MBF for Rb-82 images, it is necessary
to apply the Renkin-Crone equation [32], because of non-
linearity in the relationship between K1 and MBF:
K1 = MBF · [1−A · exp(−B/MBF)] (4)
where: A is defined between 0 and 1 and B is strictly positive.
These parameters take different values depending on the tracer
properties.
This equation shows that K1 is an increasing function of
MBF. Therefore a reduction of uncertainty in K1 is reflected
by a reduction of uncertainty in MBF. Since we are mainly
interested in the impact of motion correction on the kinetic
parameters for this study, we selected K1 as a surrogate for
MBF.
B. Measurement of uncertainty with Variational Bayes
A PET kinetic model is parameterized with a set of N
parameters p = {p1; ...; pN}. The measured signal over the M
time points is denoted y = {y1; ...; yM}. In our case N = 3,
the parameters are (K1; k2;Vb), and y is a time-activity
curve (TAC) of the myocardial tissue measured from the PET
images. Assuming that the noise on the signal is additive
Gaussian noise with precision φ , we define Θ = {p, φ} as
the full set of parameters for the generative model of the
data. The PET kinetic model f(t, p) = Cm(t), which has
been detailed in the previous section (cf. equation 2), is used






Fig. 2. Representation of a one-tissue compartment model with blood volume
fraction and reversible tracer uptake. The MBF is computed from the kinetic
parameter K1. Vb is the fraction of volume occupied by arterial blood within
the tissue.
y = {f(tj , p)}(j∈1,M).
Using Bayes’ theorem we can estimate the posterior prob-
ability distribution for the model parameters Θ given the data
y:




• P (Θ), called prior, is the distribution on the parameters
capturing prior knowledge of their value before any new
data have been considered, and is often constructed from
literature or other data sources;
• P (y | Θ), called the likelihood, is the probability of
observing y given a set of parameters Θ, and is computed
directly from the model and the observation of the data,
i.e. the TAC y in the case of PET kinetics;
• P (y), called the evidence, is the distribution of the ob-
served data, marginalized over the parameters Θ, P (y) =∫
P (y | Θ)P (Θ)dΘ. The calculation of the evidence P(y)
requires the computation of an integral which is often
intractable [24].
MCMC algorithms have been traditionally used to solve
the equations arising from Bayes’ theorem by sampling the
posterior distribution through the construction of a Markov
Chain that converges to the posterior distribution after a certain
number of iterations. One of the most common MCMC algo-
rithms is the Metropolis-Hastings (MH) method [23]. However
those algorithms could be unrealistic to use for the application
of medical images in clinical routine, because computing
parametric images requires running the fitting algorithm over
individual voxels and hence potentially millions of times for
a single image, which can take several hours [29].
Variational Bayes resolves this problem by approximating
the posterior distribution. VB has been successfully applied to
medical imaging thanks to its fast convergence and compara-
tively inexpensive computations [24], [25]. VB approximates
the true posterior P (Θ | y) with a simpler form Q(Θ). Solving
the equations from Bayes’ theorem to provide the posterior





P (y | Θ)P (Θ)
Q(Θ)
)dΘ (6)
The distribution Q(Θ) is typically chosen using the mean
field approximation; for the kinetic modelling application we
consider the parameters of the kinetic model p and the noise
model φ to be independent:
Q(Θ) = Qp(p | y)Qφ(φ | y) (7)
By using conjugate exponential priors [27], the simplified
form Q(Θ) becomes tractable and the evidence term P (y) can
be approximated iteratively. The priors chosen in this work for
the application of the VB algorithm in PET kinetic modelling
were a multivariate Normal (MVN) for the kinetic model
parameters and a Gamma distribution for the noise precision
φ:
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P (p) = MVN(p,m,Σ−1) (8)
P (φ) = Γ(φ, s, c) (9)
The interested reader can find the details of the implemen-
tation of the VB algorithm here [25], with specifics about
the non-linear model iterative optimization. Multiple starting
points were used to implement the VB algorithm on a sub grid
of values that are positive, and the best fit was kept.
Each kinetic parameter is thus represented by a marginal
distribution on pi, i ∈ {1, ..., N}, which follows a normal dis-
tribution N (µi;σ2i ) of respective mean and standard deviation
(µi;σi). The mean µi may be taken as the best estimate for
the parameter pi, while the standard deviation σi is associated
with the uncertainty in the measurement. Equally, one can
draw credible intervals for the parameters; for example, the
95% confidence interval CI95 of a parameter pi is defined as:
CI95(pi) = [µi − 1.96σi;µi + 1.96σi]
The wider this interval the more uncertain is the estimated
value of pi. Another way to look at the uncertainty is to





The advantage of the coefficient of variation is that it
represents a unitless metric that allows comparison across
different datasets. Similarly higher values of CV imply higher
uncertainty of the parameter pi.
III. METHODS AND MATERIALS
A. Simulations
1) Data: In order to confirm the validity of the parameter
and uncertainty estimates calculated by the Variational Bayes
algorithm on PET kinetic models, we used simulated time ac-
tivity curves (TACs) with known ground truth (Table I). Those
parameters were compared to a Metropolis-Hastings (MH)
implementation of the MCMC algorithm, as it is regarded as
a reference method in the literature. The values chosen for
K1,k2 and Vb correspond to typical values of stress and rest
[32].
TABLE I
VALUES OF KINETIC PARAMETERS USED FOR SIMULATIONS.
K1 k2 Vb
(mL/min/g) (1/min) (unitless)
TAC-1 (Rest) 0.47 0.12 0.48
TAC-2 (Stress) 1.08 0.21 0.50
The TACs generated were a sequence of time points,
associated with a given activity, representing the mid-frame
time of the frame. The activity at a given point was taken
as the mean activity integrated over the time duration of the
frame. The frames had the following duration: 1x10 seconds,
8x5 seconds, 3x10 seconds, 2x20 seconds and 4x60 seconds,
which is the framing strategy used in a clinical workflow for
PET cardiac studies [10] and for the clinical data used in
this study. The blood input function (BIF), corresponding to
Ca(t) in equation (1), was extracted from clinical data, using a
commercial PET cardiology software (syngo.PET Myocardial
Blood Flow - Siemens Medical Solutions USA, Inc., Malvern,
PA, USA) [33]. Noise was added to the TACs in order to
simulate realistic data. The variance of the Gaussian noise





Where y(ti) is the simulated noise free TAC at frame
i in Bq/mL, of mid-time ti in seconds, ∆ti is the i-
th frame length and α is a constant determining the
noise level. For each noise level 1000 realisations
were generated. α was varied to have 15 values:
{10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150}
and each noise level is denoted NL = {1, ..., 15}. NL values
between 10 and 15 correspond to typical values for polar map
TACs in Rb-82 dynamic PET. The purpose of simulations
was to obtain TACs that are similar to what can be
encountered in our clinical data. Since the clinical datasets
were reconstructed iteratively with an OSEM method [36], a
non-negativity constraint was added to the simulated TACs.
Potential noise realizations that generated negative activities
were discarded and regenerated until a positive value was
obtained. Since the clinical data were decay corrected, the
decay of the tracer was not included in our noise modeling.
2) Analysis: To evaluate the reliability of the mean estimate
µ̂K1 , the relative error Err for each realization of each noise




where: K1O is the ground truth value of K1
To evaluate the reliability of the uncertainty estimate σ̂K1
from the VB algorithm, 95% confidence intervals ĈIV B(K1)
on the K1 distribution were used. Those intervals were calcu-
lated for each TAC at each noise level. In order to estimate the
reliability of those confidence intervals, a frequentist approach
was used: we counted for each noise realization of a given
noise level, the number of times K1O , the ground truth value
of K1, fell into the estimated confidence intervals ĈIV B(K1).














1 if K1O ∈ ĈI
j
V B(K1)




j is the j-th random noise realization of a given noise level;
ĈI
j
V B(K1) = [µ̂
j
K1
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the respective estimated mean and standard deviation of the
K1 density distribution for the j-th TAC of a given noise level.
If the uncertainty estimate from the VB method is ac-
ceptable then the value f
ĈIV B
should be constant across the
different noise levels. As the noise increases, σ̂K1 will increase
as well, but the proportion of true values within the confidence
interval should remain the same. If the value of f
ĈIV B
is close
to 95%, the Bayesian definition of the confidence interval is
in agreement with the frequentist definition.
The same method was then applied to confidence intervals
drawn from an implementation of the Metropolis-Hastings
algorithm (CI) ĈIMH(K1). The Metropolis-Hastings chain
was run with 15,000 iterations with the first 5,000 discarded
as burn-in. The same prior distributions were used as for VB.
The frequency that the ground truth fell into the estimated












1 if K1O ∈ ĈI
j
MH(K1)




j is the j-th random noise realization of a given noise level;
and n is the number of noise realizations.
The 95% confidence interval ĈI
j
MH was directly defined
from the posterior distribution sampled from the Metropolis
Hastings algorithm.
Finally, the metric used to compare the correct estimation






1) Acquisition and reconstruction: 40 datasets from a pa-
tient cohort, referred for clinically indicated Rb-82 dynamic
PET/CT, were analyzed. Data were completely anonymised
before inclusion, collected as part of routine clinical manage-
ment and retrospectively analysed. Datasets were not taken
consecutively, as the purpose of the study was to obtain
10 datasets in each motion group. The demographics of the
patients were as follows: 25 males and 15 females, 61.3 years
old on average (± 11.5 years) and an average weight of 94.5
kgs (± 23.0 kgs). Advice from the local ethics committee
deemed that the use of retrospective anonymised patient data
did not require formal ethical approval.
The patient data were categorized in 4 different groups
based on the amount of motion, according to the method in
[13], with 10 datasets in each group. Group 0 was character-
ized by no motion, while group 1 contained light motion (less
than half the width of the left ventricular (LV) myocardial
wall), group 2 contained moderate motion (greater than half
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Fig. 3. Motion alignment workflow strategy.
a) Step 1: Workflow used for finding motion vectors of each PET frame. b)
Step 2: Difference of motion alignment strategy: either before or after the
reconstruction
partially by the automated motion correction algorithm of
syngo.PET MBF) and group 3 contained severe motion cases
(same as 2 but could not be corrected by the automated motion
correction algorithm of syngo.PET MBF, visually assessed
by review of the dynamic PET series post-correction). Only
stress images were considered for this study, since motion
is more frequent and pronounced in stress patients than rest.
Patients were administered with 1110 MBq (30 mCi) of Rb-
82, generated from a Cardiogen 82-Rb generator (Bracco
Diagnostics, Milan, Italy), which is the dose recommended
by a previous study [37] to avoid any detector saturation.
Additionally, no evidence of scanner detector saturation was
found post-acquisition. The stress agent used was adenosine,
with a dose of 140 µg/kg/min. Images were acquired on
a Biograph mCT (Siemens Medical Solutions USA, Inc.,
Knoxville, TN, USA). The data were collected for 6 minutes
after injection of the tracer. Only one CT was acquired for
both Stress and Rest protocol. The time sampling used for
the reconstruction was: 1x10 seconds, 8x5 seconds, 3x10
seconds, 2x20 seconds and 4x60 seconds (identical to the
simulations). Each dynamic frame was reconstructed with a
3D Ordered Subset Expectation Maximization (OSEM) [36]
using 2 iterations, 24 subsets and a 6.5mm full-width half
maximum Gaussian post-filter. In addition, each frame was
decay corrected.
2) PET frames realignment workflow : Frames were man-
ually realigned by three experienced observers in nuclear
cardiology. The alignment process consisted of two steps, Fig.
3. This process is referred as motion correction in this study.
The first step consisted of manually estimating the motion,
see Fig. 3a: For each dataset, one of the four last frames of the
PET series was manually aligned to the CT image and acted as
a reference. For a given subject, every observer used the same
reference PET frame to align with the CT image. Once this
reference PET frame was aligned with the CT, all other PET
frames were manually aligned to reference PET frame. Three
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dimensional translations were used to correct for motion.
The second step consisted of applying the motion realign-
ment vectors from step 1, see Fig. 3b. For the purposes of this
study this was done in two different ways:
1) A dynamic series was created by applying the motion
vectors to the raw data. The attenuation correction map,
or Mu-Map, which is a tissue density map, generated
from the estimated density of the tissue from the CT
image, was shifted for each frame, in order to keep the
CT and the PET frame aligned. By shifting the Mu-
Map, the attenuation correction was specific for each
frame. This series is referred as Motion Corrected with
Attenuation Correction (MCAC).
2) An additional dynamic series was created from the
original series, by reconstructing the dynamic series and
then applying the motion vectors defined by observers.
This series is referred as Motion Corrected (MC).
MC and MCAC images had the same motion realignment
vectors; the only difference was the stage in the reconstruction
in which the motion realignment was applied. Consequently,
the two images differed in intensity, due to the different
reconstruction methods.
3) Time-activity curves extraction: Time-activity curves
were obtained with the syngo.PET MBF software application
[38]. The default automatic motion correction was disabled
for the processing of each of the three series Original, MC
and MCAC. This software package automatically segments
the left ventricle and generates a polar map which is a 2D
representation of the 3D segmentation of the myocardium.
The arterial blood input function ROI and the myocardium
segmentation were defined automatically by syngo.PET MBF.
In order to minimize the effect of partial volume, the base
and apex definition were manually adjusted from the initial
segmentation, if found to be necessary. Similarly the long axis
could be re-angulated if required. The position of the long
axis was chosen to decrease the spillover between the blood
pool and the myocardium segmentation as much as possible.
Additionally the same long axis was chosen for processing
MCAC and MC data, so that a given TAC described the same
region of interest for both corrected series.
Syngo.PET MBF application generates 540 TACs (36 points
defined on the maximum line from the center at regular angles
for each 15 different slices). The TACs were regrouped into
4 categories: 3 coronary territories (left anterior descending-
LAD, left circumflex-LCX, right coronary artery-RCA) and
the whole myocardium (Total). Those 3 coronary territories
were the ones defined by syngo.PET MBF software as shown
in Fig. 4.
4) Analysis: The effectiveness and reliability of a motion
correction strategy was evaluated by computing the normalized





where: σK1C is the uncertainty on K1 after correction (re-
alignment of PET frames) and σK1O is the uncertainty on K1
before correction. If ∆σK1 < 0 the correction has reduced
Fig. 4. Example of a MBF polar map generated by syngo.PET MBF from a
dynamic PET acquisition. The three different territories (LAD, LCX and RCA)
can be seen. Values of the polar map are typical MBF values in mL/g/min
for a normal stress scan.
the uncertainty of K1, i.e. motion correction resulted in a
higher confidence in K1. A negative change means that the
motion corrected image provides a more reliable estimate of
K1 than the original series. A paired t-test was performed
in order to evaluate the statistical difference between σK1C
and σK1O . To compare the effectiveness of the MC method
over the MCAC, the standard deviation σK1 (see equation
3) and the mean value µK1 of each dataset were computed
for each observer. Similarly a paired t-test was computed
between σK1MC and σK1MCAC as well as between µK1MC and
µK1MCAC , where the subscript indicates the respective MC
and MCAC corrections described in section III-B2. Finally, to
evaluate the effectiveness of motion correction in comparison
to motion free datasets, the coefficient of variation CVK1 was




Fig. 5 shows representative simulated noisy rest TACs at two
different noise levels. As expected, the noisier curve leads to
a wider K̂1 distribution.
The relative error in the mean estimate µ̂K1 was robust
to different noise levels, as shown in Fig. 6. The average
error for the noise levels 5, 10 and 15 were respectively of
-0.3%, -0.9% and -2.1% for the Rest TAC, and 0.09%, -0.2%





, representing the frequency with which
the ground truth value of K1 fell into the 95% confidence
interval estimated by the different inference approaches. For
the Rest TAC, both methods gave reliable estimates of the 95%
confidence intervals (respectively ĈIMH for MH and ĈIV B
for VB); the values were on average 94.6% for VB and 94.5%
for MH algorithm. For the Stress TAC, both methods evaluated
the confidence intervals with a small difference compared










was small for the Rest TAC with an average
difference of 0.08%. Similar findings were observed for the
Stress TAC with an average difference of 1.2%. For both TACs
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Fig. 5. Examples of model fitting using VB. The top row shows two graphs representing simulated Rest TACs with different levels of noise (respectively
5 and 15). Noise level of 15 is what is typically seen in clinical data. For each graph of the top row, the inset plot shows the data for the first minute of
the acquisition. The bottom row shows the impact on the estimated distribution of the parameter K1. One can see that the graph on the bottom left, has a
narrower distribution than the graph on the bottom right (σ̂K1 = 0.019 mL/min/g for noise level = 5 and σ̂K1 = 0.084 mL/min/g for noise level =
15). Hence the noisier curve leads to higher uncertainty and less reliability.
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 for TAC Stress
Fig. 6. Relative errors for estimating K1 both TAC Rest and Stress. The
mean estimate µ̂K1 shows robustness to different noise levels. The box plot
represents the distribution of the realizations for a given noise level. The
median is represented by the middle of the box, the first and third quartiles
by the edges, and first and last decile by the whiskers.
the results did not vary substantially across the different noise
levels, as shown in Fig. 7.
B. Clinical data
The ranges of motion vectors applied for frames realignment
are detailed in Table II.
Overall a reduction in ∆σK1 after MCAC correction for
the data in the whole myocardium was observed in the three
motion groups, Fig. 8. For motion group 3, the mean reduction
for the whole myocardium was 45.3% on average for the
three observers. The biggest change was seen for the RCA
with a reduction in uncertainty of 63.6%. Similar results were
observed for motion group 2 - a reduction of 40.5% was
observed on average for the whole myocardium for the three
observers. The RCA territory showed the largest decrease at
56.0% on average. As expected, because there was less motion
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for the different noise
level and each simulated TAC (Stress and Rest). The dashed line in the graphs
shows the 95% value. The difference was small for both TACs, showing that
the 95% confidence interval was estimated with similar performance for the
VB algorithm and for MH.
TABLE II
RANGE OF MOTION VECTORS FOR OBSERVER 1 FOR EVERY DATASET OF
EACH MOTION GROUP
Light motion Moderate motion Severe motion
(group 1) (group 2) (group 3)
Range for
average [0.8 ; 2.1] [1.4 ; 5.7] [3.3 ; 8.2]
translation (mm.)
The ranges given are for relative frame realignment (i.e frame-to-frame). The
norm of the translation used to correct for relative realignment is calculated
for each frame and averaged across the number of PET frames. Average
relative alignments are computed for each dataset in each motion category.
The intervals indicate the minimum and maximum values in a motion category.
Ranges correlate with the qualitative motion categorization of the datasets.
than in groups 2 and 3, changes were smaller for group 1, but
the territory most affected remained the RCA with a mean
reduction of 10.1%. For every observer, statistical differences
between σK1MCAC and σK1O were found (p-value < 0.05) for
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both moderate and severe motion in the whole myocardium
and the RCA.
The distribution of σK1MC and σK1MCAC were found to be
very similar, as shown in Fig. 9. For the 3 motion groups,
the average values were indistinguishable for the whole my-
ocardium (p-value>0.05). Similar conclusions were observed
when comparing µK1 after MC and MCAC, (p-value>0.05).
Fig. 10 details the values of CVK1 for observer 1 before
and after MCAC. As expected, before correction CVK1 was
largest in groups with greatest motion. The distribution of
CVK1 values after MCAC was very similar across all motion
groups, with for example mean values for the total territory of
10.3% in group 0 and 8.0% for group 1, 11.5% for group 2 and
10.4% for group 3. Similar results were found for individual
territories. While there were some individual differences for
a given dataset between the three observers (data not shown),
no major differences were found in CVK1 between the three
observers. Similar observations made about Fig. 8 can be
done about the change of CVK1 after motion correction: the
uncertainty reduced most for high and moderate motion, while
being more modest for light motion.
V. DISCUSSION
In this work, a method to evaluate the reliability of motion
correction techniques through a Bayesian framework has been
developed and presented. To estimate kinetic parameters of
dynamic PET alongside with an uncertainty measurement,
the Variational Bayes framework has been chosen due to its
fast convergence and relatively inexpensive computations.
Our method was initially evaluated using simulations. The
uncertainties estimates of the kinetic parameters were found
to be well estimated at all noise levels: that is, while the
uncertainty increased progressively with an increase in noise,
as shown in Fig. 5, the proportion of simulations where the true
value fell within the confidence interval were similar from one
noise level to another. The estimates from VB were very close
to the confidence intervals derived from an MH implementa-
tion, which is normally regarded as the ”gold standard” for
Bayesian inference, albeit usually computationally impractical
for routine application to parametric estimation in medical
images. To evaluate the validity of the uncertainty measures
arrived at by Bayesian inference we compared the predictions
from VB and MH to the ensemble confidence interval from
Monte Carlo simulation, i.e. a frequentist measure. For the
simulated Rest case there was a close agreement between
Bayesian and frequentist definitions of the confidence inter-




close to 95%. For
the Stress case both Bayesian methods similarly estimate the




were around 90%, showing a small difference between fre-
quentist and Bayesian definitions of the confidence intervals.
Given the agreement between VB and MH this difference
is unlikely to be as a result of the approximations made in
the VB algorithm. However, it may well be reflective of the
nature of the non-linear kinetic model employed resulting in a
deviation between the confidence interval as might be defined
using a Bayesian or frequentists approach. In the context of
this work, this does not imply that the use of uncertainty would
be unreasonable for use as a way to assess improvements in
pre-processing, such as motion correction. The robustness of
the estimates (µ̂K1 ; σ̂K1 ) (Fig. 7) is of particular importance
for the application to motion correction, because motion can
be seen as another source of noise, albeit potentially more
complex in practice than the Gaussian noise assumption made
in the simulations.
Our implementation of the MH algorithm processed 1000
TACs in 42 minutes and 20 seconds. The VB algorithm
processed the same 1000 TACs in 6 seconds. Those results
were obtained with an Intel Xeon CPU E5-1620 of 3.70
GHz and with 16.0 GB of RAM. An implementation of the
VB algorithm can be found in the FMRIB Software library
(www.fmrib.ox.ac.uk/fsl) [25], which is freely available for
academic use.
The uncertainty metric was applied to clinical data in
order to assess the effectiveness of manual motion correction
carried out by expert clinical observers. This was done first
by comparing the values of σK1 (Fig. 8), before and after
motion correction. A significant drop in σK1 was observed
for moderate and high motion for both the total myocardial
tissue and the RCA territory, with a trend toward reduction in
the other territories. Values of CVK1 after motion correction
were also compared to CVK1 before correction and those
values found from motion-free datasets (Fig. 10). The results
showed that the level of uncertainties after motion correction
were similar between each motion group and reduced to a
comparable level to the data judged to be motion free. This
tends to imply that for the data considered here, manual motion
correction was effective for all levels of motion corruption
seen and could produce parametric estimates with comparable
accuracy to data not corrupted by substantial motion. The
observation that RCA is the most affected territory agrees with
previous research [14].
The proposed uncertainty measure was applied in the com-
parison of two different motion correction schemes, namely
MCAC and MC. With regards to uncertainty in σK1 , no
significant difference between the two strategies was seen.
The fact that the two methods produced similar uncertainties
could mean that the difference between the two schemes is less
important than other factors that contribute to the uncertainty;
for example, time sampling, intra-frame motion, scanner noise
etc. While MCAC would be the preferred correction scheme as
it takes into account the misalignment between the PET series
and the attenuation map, our results tend to imply that the MC
scheme is sufficient with regards to uncertainty measurement.
However, in order to generalize to the wider problem of
when correction should be applied, more experiments would
be needed, for example exploring the use of deformable
registration instead of rigid body translations for attenuation
correction.
By measuring the uncertainties, before and after motion
correction, we have obtained a quantitative metric that could
measure the effectiveness of motion correction. This might be
especially useful for high motion cases, where the change was
observed to be significant and thus provided reassurance that
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Change in K1 after correction for MCAC datasets
Fig. 8. Change in uncertainty after motion correction for datasets corrected with MCAC. The value ∆σK1 is plotted for the whole myocardium (Total) as
well as for each territory. A global decrease can be seen for each motion group. The difference was statistically significant for Total and RCA territory in
groups 2 and 3 (p-value < 0.05). The reduction in uncertainty was comparable between observers (median and quartiles are similar).
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Fig. 9. Bland-Altmann plot of σK1 and µK1 values after motion correction
for MC and MCAC datasets for observer 1. No statistical differences were
found between MC and MCAC correction for each motion group (p-value >
0.05)
motion correction had been effective. It is also worth noting
that while individual observers corrected the datasets to obtain
the best visual assessment of motion-free images, the final
∆σK1 was not the same for each observer. In this scenario the
uncertainty measure could potentially be used to choose the
most effective correction and hence used as an objective way
to determine whether motion correction has been of value or
to compare different motion correction algorithms. This could
be especially useful when automated motion correction is
employed allowing the user to objectively determine whether
it has been successful.
A potential limitation of this study is the choice of a
white noise model for representing the corruption induced by
motion in the simulations. While it would be very difficult
to describe mathematically the noise induced by motion, it is
certainly more complex than a Gaussian distribution as used
in our simulated data. However, in a similar manner to the
observation in the simulated data where a higher level of
noise correlated with higher uncertainty, a similar correlation
between higher level of motion and higher uncertainty was
observed in the clinical data (Fig. 8 and 10). The fact that
the decrease of uncertainty correlates with the independent
categorization of the data, implied that our assumption may
be valid as far is required for this study.
This study focused primarily on the assessment of motion
correction; there are numerous other factors that also have
an influence on the reliability of estimated K1 values. We
observed, for example, that in regions with limited tracer
signal in the late frame, which is characteristic of ischemic
or infarcted patients, the uncertainty of K1 was higher than in
healthy tissues. This might influence the evaluation of motion
correction using an uncertainty measure, because the change
in uncertainty caused by motion may be smaller than for
patients without the pathological regions of high uncertainty.
Those observations are corroborated by the values of CVK1
for light motion datasets before and after motion correction
(Fig. 10). The values did not change significantly and were
in the range of CVK1 for motion-free images, indicating
that remaining uncertainty was dominated by other factors
and that the influence of motion correction becomes less
noticeable. For this data it might thus be possible to give
an absolute threshold of K1 uncertainty on which we could
base a quality control metric. In this study we have used
uncertainty to compare different motion corrections by which
to judge whether motion correction is required or has been
successful. In principle it might be possible to establish a
threshold on the K1 uncertainty more generally on which to
base decisions regarding motion correction. However, there
are various sources of artifact and noise that contribute to
uncertainty and these will vary from dataset to dataset, making
it challenging to derive such a threshold from this study alone,
and requiring further studies with additional datasets.
Although not a limitation in this study, one issue with the
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Group 1 - light motion
Group 0 - motion free
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Group 2 - moderate motion
Group 0 - motion free
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Group 3 - severe motion
Group 0 - motion free
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CV(K1) for each motion group calculated before and 
 after motion correction and compared with motion free data 
Fig. 10. Comparison of CVK1 values before and after motion correction for MCAC datasets for observer 1. The values of CVK1 , across motion groups
after motion correction, were similar to motion free values for each territory.
proposed method in its current implementation is the inability
to translate the K1 uncertainty into MBF uncertainty. Whilst a
reduction of uncertainty in K1 will be translated in a reduction
in MBF uncertainty (cf. equation 4), it is more challenging
to translate K1 uncertainty into that of MBF for any given
image, since other parameters play a role into the translation
of K1 into MBF as shown in previous studies [5]. However
quantitative MBF uncertainty is not a necessity for the purpose
of assessing motion correction reliability; and therefore for this
limited purpose K1 can be used a surrogate for MBF.
VI. CONCLUSION
By looking at the uncertainty of K1, a new method to
evaluate the reliability of motion correction of dynamic PET
data has been developed. Here a computationally efficient
Variational Bayes algorithm has been used for PET kinetic
modelling, in order to provide uncertainty estimate of the
parameters computed. While the uncertainty is important in
itself, with regard to quality control of MBF, this method could
potentially be used as a quantitative method to evaluate motion
correction algorithms in a systematic manner, which could be
evaluated in a future clinical study.
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